Cargando…

Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy

The aims of your case report is to show the predictivity of (99m)Tc-sestamibi (MIBI) scintigraphy and doppler ultrasound imaging on secondary hyperparathyroidism (SHPT) in a patient responsive to calcimimetic treatment. Moreover, it has been reported that calcimimetic has great potential in reducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolasco, Piergiorgio, Serra, Alessandra, Loi, Maurizio, Galfré, Andrea, Piga, Mario
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905699/ https://www.ncbi.nlm.nih.gov/pubmed/20652073 http://dx.doi.org/10.1155/2010/206801

Ejemplares similares

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Concomitant occurrence of primary hyperparathyroidism (PHPT) due to mediastinal parathyroid adenoma and sublingual thyroid gland: the role of parathyroid technetium‐99m‐MIBI scintigraphy
por: Choukry, Sara, et al.
Publicado: (2017)

Absent (99m)Tc-MIBI Uptake in the Thyroid Gland during Early Phase of Parathyroid Scintigraphy in Patients with Primary and Secondary Hyperparathyroidism
por: Jovanovska, Anamarija, et al.
Publicado: (2018)

Diagnostic performance of ultrasonography, dual-phase (99m)Tc-MIBI scintigraphy, early and delayed (99m)Tc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism
por: Zhang, Rongqin, et al.
Publicado: (2020)

The role of (99m)Tc-MIBI SPECT/CT in patients with secondary hyperparathyroidism: comparison with (99m)Tc-MIBI planar scintigraphy and ultrasonography
por: Jiang, Shu-Qin, et al.
Publicado: (2020)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

Successful cinacalcet treatment of refractory secondary hyperparathyroidism due to multiple lung parathyroid adenomas
por: Sugi, Orie, et al.
Publicado: (2010)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Investigating patients with normocalcemic hyperparathyroidism: When is a parathyroid scintigraphy indicated?
por: Mazokopakis, Elias E., et al.
Publicado: (2019)

Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma
por: Das, Kalpa Jyoti, et al.
Publicado: (2015)

Semiquantitative assessment of (99m)Tc-MIBI uptake in parathyroids of secondary hyperparathyroidism patients with chronic renal failure
por: Yu, Dafu, et al.
Publicado: (2022)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report
por: Dattolo, Pietro, et al.
Publicado: (2010)

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
por: Bernardor, Julie, et al.
Publicado: (2022)

(99m)TcO(4)(-)/(99m)Tc-MIBI dual-tracer scintigraphy for preoperative localization of parathyroid adenomas
por: Huang, Zhongke, et al.
Publicado: (2018)

Parathyroid scintigraphy, histopathology correlation in patients with tropical pancreatitis and coexisting primary hyperparathyroidism
por: Padma, Subramanyam, et al.
Publicado: (2013)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

Detection of Thymoma on 99mTc MIBI Scintigraphy: Revisiting the Past
por: Parida, Girish Kumar, et al.
Publicado: (2017)

(99m)Tc MIBI Scintigraphy for Classification of Amiodarone-induced Thyrotoxicosis
por: Itzkovich, Dror, et al.
Publicado: (2022)

Primary Hyperparathyroidism: Correlation between Cervical Ultrasound and MIBI Scan
por: Salhi, Houda, et al.
Publicado: (2022)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
por: Jeong, Sohyun, et al.
Publicado: (2016)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
por: Ng, Cheng Han, et al.
Publicado: (2020)

Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism
por: Timmons, J. G., et al.
Publicado: (2021)

Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021)

(99m)Tc-MIBI SPECT/CT SCINTIGRAPHY AND ULTRASOUND OF THE ANTERIOR NECK REGION IN DIAGNOSING PARATHYROID GLAND PATHOLOGY IN PATIENTS WITH THYROID NODULES
por: Gladić Nenadić, Vedrana, et al.
Publicado: (2021)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

An Incidentally Detected Breast Cancer on Tc-99m MIBI Cardiac Scintigraphy
por: Seker, Duray, et al.
Publicado: (2012)

Breast cancer detected as an incidental finding on (99m)Tc-MIBI scintigraphy
por: Homma, Toshihiro, et al.
Publicado: (2017)

Clinical, Biochemical, and Sonographic Factors Influencing Performance of Parathormone Washout Measurement vs. (99m)Tc-MIBI Scintigraphy in the Preoperative Diagnostics of Parathyroid Adenomas
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2023)

(99m)Tc-MIBI SPECT/CT imaging had high sensitivity in accurate localization of parathyroids before parathyroidectomy for patients with secondary hyperparathyroidism
por: Zeng, Ming, et al.
Publicado: (2019)

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl
por: Eriguchi, Rieko, et al.
Publicado: (2008)

Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
por: Fisher, Marisa M, et al.
Publicado: (2015)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Cinacalcet: A Viable Therapeutic Option for Primary Hyperparathyroidism in the Elderly
por: Abusahmin, Hussam, et al.
Publicado: (2018)

Parathyroidectomy versus cinacalcet for tertiary hyperparathyroidism; a retrospective analysis
por: Dulfer, R. R., et al.
Publicado: (2019)

Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
por: Warady, Bradley A., et al.
Publicado: (2020)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020)

Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients
por: Koiwa, Fumihiko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6do96034kogmo7r0tk4hfl34ro